Patient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation in the phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS) Meeting Abstract
| Authors: | Friedlander, M. L.; Moore, K. N.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; Gourley, C.; Banerjee, S.; Oza, A.; González-Martín, A.; Aghajanian, C.; Bradley, W.; Lowe, E.; Hettle, R.; Flood, E.; Disilvestro, P. |
| Abstract Title: | Patient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation in the phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS) |
| Meeting Title: | 2019 ESMO Asia Congress |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2019 Nov 22-24 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-11-01 |
| Start Page: | mdz426 |
| Language: | English |
| ACCESSION: | WOS:000503487700217 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz426 |
| Notes: | Meeting Abstract: 224O -- Appears on page ix77 of the abstract book -- Source: Wos |
